Related Experiment Video
Updated: Aug 4, 2025

14:59
Method for Measurement of Viral Fusion Kinetics at the Single Particle Level
Published on: September 7, 2009
13.0K
Quantifying DNA-mediated liposome fusion kinetics with a fluidic trap
Rodolphe Marie1, Martin K Rasmussen1, Jonas N Pedersen1
1Department of Health Technology, Technical University of Denmark, Ørsteds Plads Build. 345C, 2800 Kongens Lyngby, Denmark. rcwm@dtu.dk.
Soft Matter
|March 31, 2023
Summary
DNA triggers synthetic liposome fusion within a nanofluidic trap. This controlled method reveals second-order kinetics, offering precise characterization for applications in drug delivery and synthetic biology.
Area of Science:
- Biomimetic nanotechnology
- Synthetic biology
- Nanofluidics
Background:
- Liposomes, synthetic lipid vesicles formed via membrane fusion, are crucial for biosensing, drug delivery, and studying biological membrane fusion.
- Current bulk methods for liposome fusion lack precise control and characterization.
Purpose of the Study:
- To demonstrate and characterize DNA-induced liposome fusion in a nanofluidic trap.
- To investigate the kinetics and parameters of liposome fusion in a confined environment.
Main Methods:
- Utilizing a nanofluidic trap for controlled liposome fusion in a 15 femtoliter volume.
- Employing DNA as an inducer for homogeneous mixing and controlled fusion.
- Characterizing liposome size and charge before and after fusion using the nanofluidic chip.
Main Results:
- Demonstrated DNA-induced liposome fusion within the nanofluidic trap.
- Established that the fusion reaction follows second-order kinetics.
- Quantified the fusion rate as (170 ± 30)/(M⁻¹s⁻¹) times the square number of DNA molecules per liposome.
- Achieved full characterization of liposome size and charge post-fusion.
Conclusions:
- Nanofluidic trapping enables precise, controlled liposome fusion with homogeneous mixing.
- The chip-based approach allows for reduced sample volume (down to 440 vesicles) and parallelization for systematic studies.
- This method advances synthetic biology, diagnostics, and drug delivery applications through controlled liposome self-assembly.

